[go: up one dir, main page]

Giddings, 1974 - Google Patents

The fractionation of factor V from human plasma

Giddings, 1974

Document ID
9628924293231971665
Author
Giddings J
Publication year
Publication venue
Thrombosis and Haemostasis

External Links

Snippet

Human plasma from normal donors and from patients with polycythaemia vera was fractionated in order to obtain a preparation of highly purified factor V. Fresh plasma was initially treated with aluminium hydroxide to remove factors II, VII, IX and X. Fibrinogen, factor …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption

Similar Documents

Publication Publication Date Title
Ui et al. Purification of hog thyroglobulin
US3682881A (en) Fractionation of plasma using glycine and polyethylene glycol
Cooper et al. Factor VIII recombination after dissociation by CaCl2
CA1068601A (en) Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
Proksch et al. The purification of the trypsin inhibitor from human pregnancy urine
Heystek et al. Contributions to the optimal use of human blood
US3717708A (en) Blood coagulation complex
Connell et al. The purification of haptoglobin
US4278594A (en) Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US5679776A (en) Process for preparing a concentrate of blood coagulation factor VIII-von willebrand factor complex from total plasma
JPS6028812B2 (en) Method for producing plasma fractions without side effects
US3904751A (en) Process for isolating a fibrin stabilizing factor from human placenta
Surgenor et al. A system for the separation of the protein components of human plasma. II. The components of the clotting process.
US2793203A (en) Process of preparing stable, highly purified gamma globulin preparations
US4977246A (en) High recovery process for antihemophilic factor
US4065445A (en) Pregnancy-specific β1 -glycoprotein and process for isolating it
Giddings The fractionation of factor V from human plasma
Casillas et al. Chromatographic behaviour of clotting factors
US4361510A (en) Blood coagulation promoting product
James et al. Development of Large‐Scale Fractionation Methods: III. Preparation of a Factor VIII Concentrate of Intermediate‐Purity 1
Wagner et al. A study of the separation of fibrinogen and antihemophilic factor (AHF) in canine, porcine, and human plasmas
US5047503A (en) Thrombin-binding substance and process for its preparation
Smith et al. A factor VIII concentrate of intermediate purity and higher potency
EP0041174B1 (en) Blood coagulation promoting product and process of preparing same
GB2146027A (en) Process for producing human interferon and method for assaying the interferon productivity of blood